Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-21388.1US
BA.5.2.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.9.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XGNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XPNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CQ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XNNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.111 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used